Anmi, a Telix Company

ANMI SA, fully owned by Telix (TLX.AX), is a pharmaceutical company developing innovative radiopharmaceutical solutions, located in Liège, Belgium.
ANMI's vision is focused on increasing patient access to new highly specific theranostic radiopharmaceuticals through streamlined and cost-effective production processes.